The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index; none of the 46 sources its claims cite is checked for support yet.
TRPV1-Mediated Microglial Autophagy Attenuates Alzheimer’s Disease-Associated Pathology and Cognitive Decline
Open accessAbstract
Autophagy is a major regulator of the ageing process of the central nervous system and neurodegeneration. Autophagy dysfunction has been implicated in the pathogenesis of Alzheimer’s disease (AD). TRPV1 was reported to regulate autophagy to protect against foam cell formation and reduce the release of inflammatory factors in atherosclerosis. In this study, pharmacological activation of TRPV1 with the TRPV1 agonist capsaicin induced autophagy in a TRPV1-dependent manner in both primary microglia and BV2 cells. TRPV1-mediated autophagy regulated glycolysis and oxidative phosphorylation by controlling the expression of genes required for aerobic glycolysis and mitochondrial respiration in primary microglia. TRPV1 agonist capsaicin decreased amyloid and phosphorylated tau pathology and reversed memory deficits by promoting microglia activation, metabolism, and autophagy in 3xTg mice. These results indicate that TRPV1 was a potential therapeutic target for AD, which suggests that capsaicin should be further assessed as a possible treatment for AD.
Overview
CoChat Summary
TL;DR
In BV2 cells, primary microglia, and 3xTg mice, capsaicin activation of TRPV1 induced microglial autophagy and metabolic reprogramming, promoted Aβ phagocytosis, reduced amyloid/tau pathology, and reversed cognitive deficits. The authors conclude that TRPV1-mediated microglial autophagy is a potential therapeutic target for Alzheimer’s disease.
Key findings
- Capsaicin induced autophagy in microglia in a TRPV1-dependent manner: LC3B-II/I increased dose-dependently at 0.01–20 μM in BV2 cells; 10 μM capsaicin produced autophagosomes, increased mitochondrial length/area and maximal respiratory capacity, and decreased glycolysis/glycolytic capacity. TRPV1−/− mice showed decreased OXPHOS and TCA-cycle gene expression.
- TRPV1 activation promoted autophagic flux and phagocytosis: capsaicin increased mRFP-GFP-LC3 puncta in BV2 cells and primary microglia, while TRPV1−/− attenuated autophagic flux; capsaicin increased FITC-Aβ1-42 uptake (2 μg/ml, 4 h) in BV2 cells and primary microglia, and this was abolished in TRPV1−/− microglia.
- TRPV1 deficiency curtailed microglial energy metabolism via autophagy inhibition: EBSS-stimulated WT microglia increased glycolytic, TCA-cycle, and pentose phosphate pathway metabolites, whereas TRPV1−/− cells showed decreased glucose 6-phosphate, nucleotides, and amino acids; glycolytic genes (Slc2a1, Slc2a3, Hk2, Aldoa, Pgk1, Eno1) and regulators Myc, Irf4, Hif1a were induced in WT but not TRPV1−/− or chloroquine-treated microglia.
- In 7-month-old 3xTg mice, capsaicin (1 mg/kg i.p. daily for 1 month) reversed novel object recognition and Y maze deficits, increased platform crosses in Morris water maze, decreased p-Tau (Ser396)/total tau and 4G8+ amyloid plaque area, and RNA-seq/WGCNA showed improved OXPHOS, mitochondrion organization, neuron/synapse function, and decreased apoptosis/oxidative stress; autophagic markers and microglial activation were increased.
Methods
- In vitro: BV2 murine microglial cells and primary microglia from newborn WT or TRPV1−/− mice; capsaicin 10 μM (dose range 0.01–20 μM for LC3) or rapamycin 2 μM; assays included Western blot, transmission electron microscopy, mRFP-GFP-LC3 autophagy flux, Seahorse OCR/ECAR, LC-MS polar metabolite profiling, qPCR, immunofluorescence, and FITC-Aβ1-42 uptake.
- In vivo: 7-month-old male and female littermate WT and 3xTg mice received capsaicin (1 mg/kg, intraperitoneally, once daily for 1 month); behavioral tests 24 h after final injection included novel object recognition, Y maze spontaneous alteration, and Morris water maze; brain tissue was used for Western blot, histology, RNA sequencing, WGCNA, and microglial morphology.
- Statistics: data presented as mean ± SEM; normality tested by Kolmogorov-Smirnov; one-way ANOVA with Tukey’s post hoc, unpaired two-tailed Student’s t test, or Mann-Whitney U test; p < 0.05 considered significant.
Limitations
- Stated: the authors note that capsaicin mechanisms can include TRPV1-independent pathways and that effects of capsaicin on AD need more research in the future.
- Evident: in vivo TRPV1 dependence was not established with TRPV1−/− or antagonist treatment in the 3xTg AD model; sample sizes were small (e.g., n = 3–9 per group), all data are rodent/cell-based with no human validation, and sex was not analyzed despite use of male and female mice.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures









Verification
Claims the paper makes
0 Valid · 1 Not valid · 33 Not checked · 84 Own results and interpretations
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Stimulation of TRPV1−/− cells resulted in a sharp decrease in the amounts of polar metabolites, such as glucose 6-phosphate (Figure 3A).”
§ TRPV1-Mediated Microglial Autophagy Attenuates Alzheimer’s Disease-Associated Pathology and Cognitive Decline > Result > TRPV1 Deficiency Curtails Energy Metabolism in Microglia via Autophagy Inhibition
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The expression levels of OXPHOS and tricarboxylic acid (TCA) cycle genes were decreased in the brain of TRPV1−/− mice compared with the WT group (Figures 1I,J).”
§ TRPV1-Mediated Microglial Autophagy Attenuates Alzheimer’s Disease-Associated Pathology and Cognitive Decline > Result > TRPV1 Activation Induced Autophagy and Energetic Metabolism in Microglia
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“3xTg mice showed significant impairment of learning and memory ability at 8-months-old compared to age-matched WT mice (Figures 4A–E)”
- Also stated in: § TRPV1 Activation Reversed Learning and Memory Impairment of 3×Tg AD Mice by Improving Autophagy · boosted
“Memory was strongly impaired in 3xTg mice as compared to the WT group (Time in the target quadrant; Figure 4D).”
§ TRPV1-Mediated Microglial Autophagy Attenuates Alzheimer’s Disease-Associated Pathology and Cognitive Decline > Result > TRPV1 Activation Reversed Learning and Memory Impairment of 3×Tg AD Mice by Improving Autophagy
boostedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § TRPV1 Activation Reversed Learning and Memory Impairment of 3×Tg AD Mice by Improving Autophagy · boosted
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“We found that upon EBSS-stimulation induced autophagy, transcripts of Myc, Irf4, and Hif1a were strongly induced in WT cells but not in TRPV1−/−-deficient or chloroquine-treated microglia (Figures 3B,C).”
§ TRPV1-Mediated Microglial Autophagy Attenuates Alzheimer’s Disease-Associated Pathology and Cognitive Decline > Result > TRPV1 Deficiency Curtails Energy Metabolism in Microglia via Autophagy Inhibition
boosted- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“TRPV1 agonist capsaicin decreased amyloid and phosphorylated tau pathology and reversed memory deficits by promoting microglia activation, metabolism, and autophagy in 3xTg mice.”
§ TRPV1-Mediated Microglial Autophagy Attenuates Alzheimer’s Disease-Associated Pathology and Cognitive Decline > Abstract
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
71 more claims
Create a free account to see all 118 claims and to verify the 40 references still open.
- It may state two separate claims as one. 24
- Probably not a substantial claim. 27
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ TRPV1-Mediated Microglial Autophagy Attenuates Alzheimer’s Disease-Associated Pathology and Cognitive Decline > Result > Genome-Wide RNA Sequencing of 3xTg Mice Reveals Treatment with Capsaicin Alleviates Pathological Hallmarks of AD in 3xTg Mice
“the colocalization of LC3B/Iba-1 (Figures 9A,B) or LC3B/NeuN (Figures 9C,D) were significantly decreased”
§ TRPV1-Mediated Microglial Autophagy Attenuates Alzheimer’s Disease-Associated Pathology and Cognitive Decline > Result > Genome-Wide RNA Sequencing of 3xTg Mice Reveals Treatment with Capsaicin Alleviates Pathological Hallmarks of AD in 3xTg Mice
“(A, C) Representative images showing the colocalization of LC3B/NeuN (A) or LC3B/Iba-1 (C). (B, D) Quantification of colocalization of LC3B/NeuN (B) or LC3B/Iba-1 (D)”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ TRPV1-Mediated Microglial Autophagy Attenuates Alzheimer’s Disease-Associated Pathology and Cognitive Decline > Methods > Western Blotting
“| Rabbit monodonal anti-Atg16L1 (D6D5) | Cell Signaling Technology | 4445T | 1:1000 | — |”
§ TRPV1-Mediated Microglial Autophagy Attenuates Alzheimer’s Disease-Associated Pathology and Cognitive Decline > Methods > Western Blotting
“| Rabbit monodonal anti-Atg7 (D12B11) | Cell Signaling Technology | 4445T | 1:1000 | — |”
Citations
Cites
Cytoscape: A software Environment for integrated models of biomolecular interaction networks
Shannon, P., Markiel, A., Ozier, O., Baliga, N. S., Wang, J. T., Ramage, D., Amin, N., Schwikowski, B., & Ideker, T. (2003) · Genome Research · doi:10.1101/gr.1239303 · Cited by 51,888
WGCNA: an R package for weighted correlation network analysis
Langfelder, P., & Horvath, S. (2008) · BMC Bioinformatics · doi:10.1186/1471-2105-9-559 · Cited by 27,252
Metascape provides a biologist-oriented resource for the analysis of systems-level datasets
Zhou, Y., Zhou, B., Pache, L., Chang, M., Khodabakhshi, A. H., Tanaseichuk, O., Benner, C., & Chanda, S. K. (2019) · Nature Communications · doi:10.1038/s41467-019-09234-6 · Cited by 14,611
Polazzi, E., Mengoni, I., Caprini, M., Peña-Altamira, E., Kurtys, E., & Monti, B. (2013) · Neurosignals · doi:10.1159/000337115 · Cited by 8,994
Autophagy: Renovation of Cells and Tissues
Mizushima, N., & Komatsu, M. (2011) · Cell · doi:10.1016/j.cell.2011.10.026 · Cited by 6,418
A General Framework for Weighted Gene Co-Expression Network Analysis
Zhang, B., & Horvath, S. (2005) · Statistical Applications in Genetics and Molecular Biology · doi:10.2202/1544-6115.1128 · Cited by 5,684 · cited 2×
“Weighted gene co-expression network analyses (WGCNA) were performed to analyze 3xTg mice brain co-expression networks that were changed after capsaicin treatment (Zhang and Horvath, 2005).”
MethodTriple-Transgenic Model of Alzheimer’s Disease with Plaques and Tangles
Oddo, S., Caccamo, A., Shepherd, J. D., Murphy, M. P., Golde, T. E., Kayed, R., Metherate, R., Mattson, M. P., Akbari, Y., & LaFerla, F. M. (2003) · Neuron · doi:10.1016/s0896-6273(03)00434-3 · Cited by 4,126
Microglia: Active sensor and versatile effector cells in the normal and pathologic brain
Hanisch, U.-K., & Kettenmann, H. (2007) · Nature Neuroscience · doi:10.1038/nn1997 · Cited by 3,676
Rubinsztein, D. C., Mariño, G., & Kroemer, G. (2011) · Cell · doi:10.1016/j.cell.2011.07.030 · Cited by 2,107 · cited 1×
“The abundance of autophagy-related proteins, such as Beclin1, ATG5, and ATG7, declines with age and is exacerbated during AD (Pickford et al., 2008; Lipinski et al., 2010; Rubinsztein et al., 2011; Lucin et al., 2013).”
BackgroundSignals from the lysosome: a control centre for cellular clearance and energy metabolism
Settembre, C., Fraldi, A., Medina, D. L., & Ballabio, A. (2013) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3565 · Cited by 1,697
Ji, R.-R., Samad, T. A., Jin, S.-X., Schmoll, R., & Woolf, C. J. (2002) · Neuron · doi:10.1016/s0896-6273(02)00908-x · Cited by 1,238
Molecular Interplay between Mammalian Target of Rapamycin (mTOR), Amyloid-β, and Tau
Caccamo, A., Majumder, S., Richardson, A., Strong, R., & Oddo, S. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.100420 · Cited by 881
Compromised autophagy and neurodegenerative diseases
Menzies, F. M., Fleming, A., & Rubinsztein, D. C. (2015) · Nature Reviews Neuroscience · doi:10.1038/nrn3961 · Cited by 851
A Breakdown in Metabolic Reprogramming Causes Microglia Dysfunction in Alzheimer's Disease
Baik, S. H., Kang, S., Lee, W., Choi, H., Chung, S., Kim, J.-I., & Mook-Jung, I. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.06.005 · Cited by 843
Lipinski, M. M., Zheng, B., Lu, T., Yan, Z., Py, B. F., Ng, A., Xavier, R. J., Li, C., Yankner, B. A., Scherzer, C. R., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1009485107 · Cited by 680
Young, K., & Morrison, H. (2018) · Journal of Visualized Experiments · doi:10.3791/57648 · Cited by 574
Dynamics of the Microglial/Amyloid Interaction Indicate a Role in Plaque Maintenance
Bolmont, T., Haiss, F., Eicke, D., Radde, R., Mathis, C. A., Klunk, W. E., Kohsaka, S., Jucker, M., & Calhoun, M. E. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.4814-07.2008 · Cited by 526
Lucin, K. M., O’Brien, C. E., Bieri, G., Czirr, E., Mosher, K. I., Abbey, R. J., Mastroeni, D. F., Rogers, J., Spencer, B., Masliah, E., et al. (2013) · Neuron · doi:10.1016/j.neuron.2013.06.046 · Cited by 374
Luo, R., Su, L.-Y., Li, G., Yang, J., Liu, Q., Yang, L.-X., Zhang, D.-F., Zhou, H., Xu, M., Fan, Y., et al. (2020) · Autophagy · doi:10.1080/15548627.2019.1596488 · Cited by 364
Intracellular signaling in M‐CSF‐induced microglia activation: Role of Iba1
Imai, Y., & Kohsaka, S. (2002) · Glia · doi:10.1002/glia.10149 · Cited by 359
Temporal and regional progression of Alzheimer’s disease‐like pathology in 3xTg‐AD mice
Belfiore, R., Rodin, A., Ferreira, E., Velazquez, R., Branca, C., Caccamo, A., & Oddo, S. (2019) · Aging Cell · doi:10.1111/acel.12873 · Cited by 332
Costa, B., Giagnoni, G., Franke, C., Trovato, A. E., & Colleoni, M. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705920 · Cited by 289
Pickford, F., Masliah, E., Britschgi, M., Lucin, K., Narasimhan, R., Jaeger, P. A., Small, S., Spencer, B., Rockenstein, E., Levine, B., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci33585 · Cited by 268
Lee, J.-W., Nam, H., Kim, L. E., Jeon, Y., Min, H., Ha, S., Lee, Y., Kim, S.-Y., Lee, S. J., Kim, E.-K., et al. (2019) · Autophagy · doi:10.1080/15548627.2018.1556946 · Cited by 260
OXPHOS mutations and neurodegeneration
Koopman, W. J. H., Distelmaier, F., Smeitink, J. A., & Willems, P. H. (2013) · The EMBO Journal · doi:10.1038/emboj.2012.300 · Cited by 254
Phenotypic convergence: distinct transcription factors regulate common terminal features
Konstantinides, N., Kapuralin, K., Fadil, C., Barboza, L., Satija, R., & Desplan, C. (2018) · Cell · doi:10.1016/j.cell.2018.05.021 · Cited by 226 · cited 1×
“To investigate the changes on different kinds of synaptic receptors, mRNA levels of cholinergic, glutamatergic, and GABAergic receptors were detected (Konstantinides et al., 2018).”
BackgroundVeldhuis, W. B., van der Stelt, M., Wadman, M. W., van Zadelhoff, G., Maccarrone, M., Fezza, F., Veldink, G. A., Vliegenthart, J. F. G., Bär, P. R., Nicolay, K., et al. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-10-04127.2003 · Cited by 179
Autophagy Controls Acquisition of Aging Features in Macrophages
Stranks, A. J., Hansen, A. L., Panse, I., Mortensen, M., Ferguson, D. J. P., Puleston, D. J., Shenderov, K., Watson, A. S., Veldhoen, M., Phadwal, K., et al. (2015) · Journal of Innate Immunity · doi:10.1159/000370112 · Cited by 163
TRPV1 on astrocytes rescues nigral dopamine neurons in Parkinson’s disease via CNTF
Nam, J. H., Park, E. S., Won, S.-Y., Lee, Y. A., Kim, K. I., Jeong, J. Y., Baek, J. Y., Cho, E. J., Jin, M., Chung, Y. C., et al. (2015) · Brain · doi:10.1093/brain/awv297 · Cited by 140
Li, B.-H., Yin, Y.-W., Liu, Y., Pi, Y., Guo, L., Cao, X.-J., Gao, C.-Y., Zhang, L.-L., & Li, J.-C. (2014) · Cell Death and Disease · doi:10.1038/cddis.2014.146 · Cited by 136
TRPV1 sustains microglial metabolic reprogramming in Alzheimer's disease
Lu, J., Zhou, W., Dou, F., Wang, C., & Yu, Z. (2021) · The EMBO Reports · doi:10.15252/embr.202052013 · Cited by 121 · cited 3×
“, Santa Clara, CA, United States) as previously described (Lu et al., 2021).”
MethodSelf-citationAutophagy proteins in antigen processing for presentation on MHC molecules
Münz, C. (2016) · Immunological Reviews · doi:10.1111/imr.12422 · Cited by 121
Baron, R., Babcock, A. A., Nemirovsky, A., Finsen, B., & Monsonego, A. (2014) · Aging Cell · doi:10.1111/acel.12210 · Cited by 118
Autophagy in Age-Associated Neurodegeneration
Metaxakis, A., Ploumi, C., & Tavernarakis, N. (2018) · Cells · doi:10.3390/cells7050037 · Cited by 117
Mechanisms of Neuronal Homeostasis: Autophagy in the Axon
Maday, S. (2016) · Brain Research · doi:10.1016/j.brainres.2016.03.047 · Cited by 110
Plescher, M., Seifert, G., Hansen, J. N., Bedner, P., Steinhäuser, C., & Halle, A. (2018) · Glia · doi:10.1002/glia.23318 · Cited by 100
Dello Russo, C., Lisi, L., Feinstein, D. L., & Navarra, P. (2013) · Glia · doi:10.1002/glia.22433 · Cited by 96 · cited 1×
“Mounting studies have evaluated the role of autophagy on neuron in neurodegeneration, emerging evidence shows that autophagy may also be involved in microglia immune function (Dello Russo et al., 2013).”
BackgroundDu, Y., Fu, M., Huang, Z., Tian, X., Li, J., Pang, Y., Song, W., Tian Wang, Y., & Dong, Z. (2020) · Aging Cell · doi:10.1111/acel.13113 · Cited by 95
Rexach, J. E., Polioudakis, D., Yin, A., Swarup, V., Chang, T. S., Nguyen, T., Sarkar, A., Chen, L., Huang, J., Lin, L.-C., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.108398 · Cited by 94
Li, Q., Li, L., Wang, F., Chen, J., Zhao, Y., Wang, P., Nilius, B., Liu, D., & Zhu, Z. (2013) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-013-1274-4 · Cited by 91
Wang, J., Sun, B.-L., Xiang, Y., Tian, D.-Y., Zhu, C., Li, W.-W., Liu, Y.-H., Bu, X.-L., Shen, L.-L., Jin, W.-S., et al. (2020) · Translational Psychiatry · doi:10.1038/s41398-020-00918-y · Cited by 87
Balleza-Tapia, H., Crux, S., Andrade-Talavera, Y., Dolz-Gaiton, P., Papadia, D., Chen, G., Johansson, J., & Fisahn, A. (2018) · eLife · doi:10.7554/elife.37703 · Cited by 68
Xu, X., Farkas-Szallasi, T., Lundberg, J. M., Hökfelt, T. G. M., Wiesenfeld‐Hallin, Z., & SZALLASI, A. (1997) · Brain Research · doi:10.1016/s0006-8993(96)01444-8 · Cited by 61
Dubový, P., Klusáková, I., Hradilová-Svíženská, I., Joukal, M., & Boadas-Vaello, P. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00040 · Cited by 57
BECN1/Beclin 1 Sorts Cell-Surface APP/amyloid β Precursor Protein for Lysosomal Degradation
Swaminathan, G., Zhu, W., & Plowey, E. D. (2016) · Autophagy · doi:10.1080/15548627.2016.1234561 · Cited by 50
KCa3.1 constitutes a pharmacological target for astrogliosis associated with Alzheimer's disease
Yi, M., Yu, P., Lu, Q., Geller, H. M., Yu, Z., & Chen, H. (2016) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2016.08.008 · Cited by 45
Self-citationBhatia, H. S., Roelofs, N., Muñoz, E., & Fiebich, B. L. (2017) · Scientific Reports · doi:10.1038/s41598-017-00225-5 · Cited by 41
Wei, T., Wang, Y., Xu, W., Liu, Y., Chen, H., & Yu, Z. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.104588 · Cited by 34
Self-citationMori, N., Kawabata, F., Matsumura, S., Hosokawa, H., Kobayashi, S., Inoue, K., & Fushiki, T. (2011) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00645.2009 · Cited by 26
Yeung, J. H. Y., Calvo‐Flores Guzmán, B., Palpagama, T. H., Ethiraj, J., Zhai, Y., Tate, W. P., Peppercorn, K., Waldvogel, H. J., Faull, R. L. M., & Kwakowsky, A. (2020) · Journal of Neurochemistry · doi:10.1111/jnc.15099 · Cited by 26
Yu, Z., Yi, M., Wei, T., Gao, X., & Chen, H. (2017) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2017.00319 · Cited by 23
Self-citationTong, J., Lai, Y., Yao, Y.-A., Wang, X.-J., Shi, Y.-S., Hou, H.-J., Gu, J.-Y., Chen, F., & Liu, X.-B. (2018) · Cellular Physiology and Biochemistry · doi:10.1159/000490822 · Cited by 22
Yi, M., Dou, F., Lu, Q., Yu, Z., & Chen, H. (2016) · Neuroscience Letters · doi:10.1016/j.neulet.2016.05.004 · Cited by 18
Self-citationResilience to Capsaicin-Induced Mitochondrial Damage in Trigeminal Ganglion Neurons
Shibata, M., Kayama, Y., Takizawa, T., Ibata, K., Shimizu, T., Yuzaki, M., Suzuki, N., & Nakahara, J. (2020) · Molecular Pain · doi:10.1177/1744806920960856 · Cited by 16
Balleza-Tapia, H., Dolz-Gaiton, P., Andrade-Talavera, Y., & Fisahn, A. (2020) · Molecular Neurobiology · doi:10.1007/s12035-019-01779-3 · Cited by 9
Cited by
Role of Calcium Modulation in the Pathophysiology and Treatment of Alzheimer’s Disease
Baracaldo-Santamaría, D., Avendaño-Lopez, S. S., Ariza-Salamanca, D. F., Rodríguez-Giraldo, M., Calderón‐Ospina, C., González-Reyes, R. E., & Nava-Mesa, M. O. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24109067 · Cited by 93
Beneficial Effects of Capsaicin in Disorders of the Central Nervous System
Pasierski, M., & Szulczyk, B. (2022) · Molecules · doi:10.3390/molecules27082484 · Cited by 84
TRPV1: The key bridge in neuroimmune interactions
Chen, J., Sun, W., Zhu, Y., Zhao, F., Deng, S., Tian, M. M., Wang, Y., & Gong, Y. (2024) · Journal of Intensive Medicine · doi:10.1016/j.jointm.2024.01.008 · Cited by 64
Huang, Q., Wang, Y., Chen, S., & Liang, F. (2023) · Aging and disease · doi:10.14336/ad.2023.0807 · Cited by 62
Sun, C., Gao, X., Sh, S., Wang, S., Shan, Y., Li, L., Xing, C., Guan, H., & Du, H. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.114550 · Cited by 44
Metadata
- Authors
- Wang, C., Huang, W., Lu, J., Chen, H., & Yu, Z.
- Affiliations
- Shanghai Jiao Tong University (CN)
- The Affiliated Yongchuan Hospital of Chongqing Medical University (CN)
- Corresponding author
- Chen, Hongzhuan
- Yu, Zhihua
- Venue
- Frontiers in Pharmacology
- Publisher
- Frontiers Media SA
- Published
- 2022-01-18
- Volume
- 12
- Pages
- 763866-763866
- ISSN
- 1663-9812 (ISSN-L)
- PMC
- PMC8804218
- OpenAlex
- W4205466844
- Semantic Scholar
- 5a96e5184fbd448863cb84c5f6a30923a8835348
- Cited by
- 56
- References
- 55
- Citations by year
- 2026: 6 · 2025: 9 · 2024: 21 · 2023: 13 · 2022: 7
- FWCI
- 4.07
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Frontiers in Pharmacology (publishedVersion, cc-by)
- PubMed (publishedVersion)
- PubMed Central (publishedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Natural Science Foundation of China (82173791, 81773699)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
- Keywords
- TRPV1, Alzheimer's disease, capsaicin, microglial activation, aerobic glycolysis, oxidative phosphorylation, amyloid pathology, tau phosphorylation, memory impairment, 3xTg-AD mice, neurodegeneration, therapeutic target
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-11-19, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-11-19 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.